Delivery Order SPE2DB22D2006-SPE2DB25FV8SJ

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,921.29, is a Delivery Order for VISCOAT SYRINGE 0.5ML, with a Firm Fixed Price pricing type and an ultimate completion date of November 18, 2024. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,666.80 firm fixed price contract is for the delivery of VISCOAT SYRINGE 0.5ML products, with a completion date of February 18, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $22,441.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D2206) for the procurement of VISCOAT SYRINGE 0.75ML medical supplies, with a performance period through November 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,833.50, is for the delivery of 0.5 mL VISCOAT syringes. It is a firm fixed-price delivery order contract with a completion date of January 27, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November...
This federal contract award, valued at $8,280.47, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This federal contract award, valued at $4,666.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VISCOAT SYRINGE 0.5ML, a medical supply item. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on January 8, 2025. This award is not associated with a set-aside program and is part of Amerisourcebergen's broader Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,371.51, is for the delivery of 0.5 mL viscoat syringes. The award is a Delivery Order against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,349.54 fixed-price delivery order is for the supply of 0.5 mL VISCOAT syringes, with a completion date of February 26, 2025. This contract award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $2,333.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 0.5mL VISCOAT syringes, with a completion date of November 14, 2024. This award is part of an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,889.00 Delivery Order contract is for the provision of 0.5mL "VISCOAT SYRINGE" medical supplies. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV8SJ
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,022.40, is a delivery order with a firm fixed-price pricing type. The contract is for the supply of "VISCOAT SYRINGE 0.5ML" medical products, with a completion date of February 27, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any major subcontractors.

Generated 5/28/25, 10:58 AM